Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis

BACKGROUND: Chronic hepatitis B virus (HBV) infection represents a serious global health problem and resistance to lamivudine (LAM) has become a serious clinical challenge. Previous rescue therapy for the treatment of chronic LAM-resistant hepatitis B infected patients included switching to entecavi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Yun-Jian, Liu, Jun-Ying, Tong, Shi-Wen, Hu, Huai-Dong, Zhang, Da-Zhi, Hu, Peng, Ren, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173393/
https://www.ncbi.nlm.nih.gov/pubmed/21824397
http://dx.doi.org/10.1186/1743-422X-8-393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173393/
https://www.ncbi.nlm.nih.gov/pubmed/21824397
http://dx.doi.org/10.1186/1743-422X-8-393

Ejemplares similares